METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE LIVER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE LIVER trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver-Directed chemo shows promise for eye cancer metastases
Disease control OngoingThis phase 2 trial tests a procedure called transarterial chemoembolization (TACE) for people with uveal melanoma that has spread to the liver. Doctors inject a chemotherapy drug (carmustine) mixed with an oily contrast agent (Lipiodol) directly into the liver's blood supply, the…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Electric field device takes on liver tumors in early trial
Disease control OngoingThis early-phase study tests a portable device that sends gentle electric fields to the liver, combined with chemotherapy and a targeted drug (bevacizumab), in people whose cancer has spread to the liver and stopped responding to standard treatments. The main goal is to find the …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy aims to shrink Hard-to-Treat neuroendocrine liver tumors
Disease control OngoingThis phase 2 pilot study tests whether combining the immunotherapy drug pembrolizumab (Keytruda) with liver-directed treatments (like embolization or radiation) or peptide receptor radionuclide therapy (PRRT) can shrink tumors in people with well-differentiated neuroendocrine tum…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase: PHASE2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Jun 26, 2026 13:09 UTC
-
Double-Dye MRI could sharpen liver cancer detection
Diagnosis OngoingThis study tests whether using two contrast dyes during MRI can better tell apart benign and malignant liver lesions. About 100 patients with known or suspected liver growths will receive both gadoxetate disodium and gadobutrol before imaging. The goal is to see if the combinatio…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LIVER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC